<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04289298</url>
  </required_header>
  <id_info>
    <org_study_id>19-09020810-02</org_study_id>
    <secondary_id>5P50MH113838-03</secondary_id>
    <nct_id>NCT04289298</nct_id>
  </id_info>
  <brief_title>Reaching and Engaging Depressed Senior Center Clients</brief_title>
  <acronym>REDS II</acronym>
  <official_title>Reaching and Engaging Depressed Senior Center Clients Phase II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the feasibility of two types of group therapy sessions.
      The research is being done because the researchers are trying to learn if these approaches
      could be used by therapist in the community social service agencies to treat older adults
      with depression.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in clinically significant depressive symptoms, as measured on the Montgomery Asberg Depression Rating Scale (MADRS)</measure>
    <time_frame>Baseline, 6 weeks, 12 weeks, 15 weeks</time_frame>
    <description>The Montgomery Asberg Depression Rating Scale (MADRS) is used for rating the severity of depressive symptoms. The MADRS ranges from 0 to 60, with higher scores indicating greater severity of depression.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in assessment of quality of life, as measured by the World Health Organization Quality of Life (WHOQOL-BREF) scale</measure>
    <time_frame>Baseline, 6 weeks, 12 weeks, 15 weeks</time_frame>
    <description>The World Health Organization Quality of Life (WHOQOL-BREF) scale assesses quality of life within the context of an individual's culture, value systems, personal goals, standards, and concerns. The WHOQOL-BREF ranges from 0-100, with higher scores indicating a higher quality of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported depressed mood, as measured by daily 10-point likert ratings</measure>
    <time_frame>Daily for 15 weeks</time_frame>
    <description>Scores are measured on daily 10-point likert ratings of depressed mood, with higher scores indicating higher levels of depressed mood. (0 = not sad, 10 = most sad)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Depression in Old Age</condition>
  <arm_group>
    <arm_group_label>Engage-M Hybrid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive 6 individual in-person therapy sessions, 3 self-administered sessions, and 2 group sessions. Each session will last approximately 60 minutes. During the sessions, the therapist will encourage the participant to engage in physical and social activities that are pleasurable or rewarding.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wellness of Mind and Body (W-MH)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive 6 individual in-person sessions, 3 self-administered sessions, and 2 group sessions. Each session will last approximately 60 minutes. During the sessions, the therapist will educate the participant about health and mental health.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Engage-M Hybrid</intervention_name>
    <description>Therapist will encourage participants to engage in physical and social activities that are pleasurable or rewarding. Engage is a stepped care psychotherapy based on what is known about how older adults respond to depression interventions. Stepped care is a model of treatment that starts with the minimum effective therapeutic techniques first, and then based on how well people respond to treatment, additional therapeutic techniques are added until people are recovered from their depression.</description>
    <arm_group_label>Engage-M Hybrid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Wellness of Mind and Body (W-MH)</intervention_name>
    <description>Educational sessions about health and mental health. An active intervention focusing on psychoeducation and de-stigmatization of health and mental health conditions. These sessions are commonly part of senior centers programs. W-MH will offer mental health referral to a clinic or primary care physician as part of senior center procedures for clients with positive PHQ-9s.</description>
    <arm_group_label>Wellness of Mind and Body (W-MH)</arm_group_label>
    <other_name>W-MH</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 55 years' old

          -  PHQ-9 Score of ≥ 10

          -  English or Spanish speaking

          -  MOCA ≥ 24

          -  Member of/attends one of the REDS Senior Centers

          -  Capacity to provide written consent for both research assessment and the Engage-M
             Hybrid Intervention or the Wellness of Mind and Body (W-MH) intervention.

        Exclusion Criteria:

          -  Current active suicidal ideation defined by MADRS Suicide Item ≥ 4 (probably better
             off dead. Suicidal thoughts are common, and suicide is considered as a possible
             solution, but without specific plans or intention).

          -  Presence of psychiatric diagnoses other than unipolar, non-psychotic major depression
             or generalized anxiety disorder by SCID-IV.

          -  Severe or life-threatening medical illness (e.g., end stage organ failure).

          -  Currently seeing an individual psychotherapist *(if individuals are willing to go on a
             hiatus from their individual psychotherapist for the 15 weeks of the study, and meet
             all inclusion criteria, they will be considered eligible).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Marino, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Cornell Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Iris Yang, B.S.</last_name>
    <phone>9149974327</phone>
    <email>irissunyang@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>White Plains</city>
        <state>New York</state>
        <zip>10605</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Iris Yang, B.S.</last_name>
      <phone>844-999-8746</phone>
      <phone_ext>709</phone_ext>
      <email>irissunyang@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Patricia Marino, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>February 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>depression</keyword>
  <keyword>geriatric</keyword>
  <keyword>psychotherapy</keyword>
  <keyword>group</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data from this study is submitted to the National Database for Clinical Trials related to Mental Illness (NDCT). The NDCT is run by NIH and allows researchers studying mental health to collect and share information with each other. Researchers must apply to NIH in order to be allowed access to the data for 1 year's time; after which they must re-apply.</ipd_description>
    <ipd_time_frame>Data will be available as per NIMH's data sharing policy.</ipd_time_frame>
    <ipd_access_criteria>Access criteria is determined by NIMH and can be requested by applying online.</ipd_access_criteria>
    <ipd_url>https://nda.nih.gov/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

